Evolv Technologies Holdings Bilan de santé
Santé financière contrôle des critères 6/6
Evolv Technologies Holdings possède un total de capitaux propres de $119.4M et une dette totale de $28.6M, ce qui porte son ratio d'endettement à 23.9%. Son actif total et son passif total sont $304.4M et de $185.0M.
Informations clés
23.95%
Ratio d'endettement
US$28.60m
Dette
| Ratio de couverture des intérêts | n/a |
| Argent liquide | US$69.04m |
| Fonds propres | US$119.42m |
| Total du passif | US$184.99m |
| Total des actifs | US$304.41m |
Mises à jour récentes de la santé financière
Recent updates
EVLV: Raised 2026 Guidance And Venue Wins Will Support Future Upside
Analysts have raised their fair value estimate for Evolv Technologies Holdings from $9.50 to $10.00, citing updated assumptions around discount rates, revenue growth, profit margins, and a higher future P/E multiple as key drivers of the new price target. What's in the News Evolv raised its 2026 revenue guidance to a range of US$172 million to US$178 million, compared with prior guidance of US$160 million to US$165 million, following an Analyst and Investor Day focused on vision, strategy, growth initiatives, products, technology and financial goals.
EVLV: Stadium And Hospital Security Contracts Will Drive Multi Year Upside
Analysts have adjusted their price target on Evolv Technologies Holdings to $10.50. The change reflects updated assumptions around discount rate, revenue growth, profit margin and future P/E, rather than a shift in fair value.
EVLV: Expanding Stadium And Hospital Contracts Will Drive Long Term Upside
Analysts have modestly adjusted their price target on Evolv Technologies Holdings, keeping fair value at $9.50 while fine tuning assumptions around the discount rate, revenue growth, profit margin, and future P/E to reflect updated views on the company’s risk profile and long term earnings potential. What's in the News Evolv renewed and expanded its subscription agreement with the Houston Astros, upgrading the venue wide deployment at 41,000 seat Daikin Park to Express Gen2 hardware and adding eXpedite bag screening for staff, which brings Evolv’s professional baseball customer count to twelve.EVLV: Expanded Stadium And Hospital Contracts Will Support Multi Year Upside
Analysts have nudged their price target for Evolv Technologies Holdings up from $10.00 to $10.50. They point to updated assumptions around slightly higher revenue growth, a marginally lower discount rate, and a modestly lower future P/E as key drivers of the change.EVLV: Expanding Stadium And Healthcare Contracts Will Support Bullish Multi Year Upside
Analysts have adjusted their price target on Evolv Technologies Holdings to $10.00, with the change linked to updated assumptions around revenue growth, profit margins and the future P/E multiple, even though the headline fair value figure remains stated at $10.00. What's in the News Evolv extended and expanded its multi year hardware and software subscription with Bank of America Stadium in Charlotte, upgrading nearly twenty Evolv Express systems to Gen2 hardware and adding eXpedite bag screening ahead of the March 7, 2026 Charlotte FC home opener (Client announcement).EVLV: Venue Partnerships Will Set Up A Breakout Year In 2026
Analysts have adjusted their price targets for Evolv Technologies Holdings slightly, reflecting updated assumptions around discount rates, revenue growth of about 17.85%, profit margins near 8.19%, and a future P/E of roughly 139.15x. These inputs support a refined view of fair value that remains around $9.50 per share.EVLV: Q3 Outperformance And 2026 ARR Focus Will Support Bullish Case
Analysts lifted their price target on Evolv Technologies Holdings to US$10 from US$9, citing recent quarterly performance and expectations that annual recurring revenue growth could outpace revenue growth by 2026. Analyst Commentary Recent commentary from bullish analysts centers on a higher conviction view of Evolv Technologies Holdings after its latest quarterly report, with particular attention on the relationship between annual recurring revenue and total revenue over the medium term.EVLV: ARR Momentum Will Set Up A Breakout Year In 2026
Narrative Update on Evolv Technologies Holdings Analysts have raised their price target on Evolv Technologies Holdings to $10 from $9, citing a recent quarterly performance described as a strong beat and noting expectations that by 2026 annual recurring revenue growth could exceed reported revenue growth. Analyst Commentary The latest price target change to US$10 highlights that some on the Street see upside potential, but even supportive research comes with clear caveats around how the story could play out over the next few years.EVLV: Q3 Beat And 2026 ARR Breakout Potential Support Bullish Outlook
Analysts have raised their fair value estimate for Evolv Technologies Holdings to $10.00 from $8.25 after a Q3 performance that they describe as very strong, and based on expectations that annual recurring revenue growth could outpace overall revenue growth by 2026. Analyst Commentary Bullish analysts are pointing to Evolv Technologies Holdings' Q3 performance as a key support for higher valuation expectations, with recent fair value and price target increases signaling growing confidence in the company’s execution.EVLV: ARR Momentum Will Drive A Breakout Year In 2026
Analysts lifted their price target on Evolv Technologies Holdings by $1 to $10, citing a substantial Q3 beat and expectations that accelerating ARR growth will position 2026 as a breakout year. Analyst Commentary While the latest price target increase to $10 reflects optimism around Evolv Technologies Holdings' Q3 performance and medium term growth prospects, not all market observers are uniformly bullish.Multi-Year Contracts With Public Schools And Hospitals Will Expand Markets
The analyst price target for Evolv Technologies Holdings has been raised significantly, driven by a Q2 earnings beat, upgraded FY25 revenue guidance, improved business outlook following regulatory clarity and management changes, as well as momentum across key industry verticals, lifting the consensus fair value from $7.19 to $9.50. Analyst Commentary Q2 earnings beat on both revenue and AEBITDA, leading to upgraded financial forecasts for FY25.AI Screening Will Expand Public Safety Applications
Heightened demand for advanced security and regulatory mandates drive strong growth potential for recurring subscription revenue across diverse markets.The Price Is Right For Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Even After Diving 28%
May 21
After Leaping 29% Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Shares Are Not Flying Under The Radar
Feb 16Here's Why We're Not At All Concerned With Evolv Technologies Holdings' (NASDAQ:EVLV) Cash Burn Situation
Jan 23After Leaping 33% Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Shares Are Not Flying Under The Radar
Dec 14Analyse de la situation financière
Passif à court terme: Les actifs à court terme de EVLV ( $151.3M ) dépassent ses passifs à court terme ( $123.0M ).
Passif à long terme: Les actifs à court terme de EVLV ( $151.3M ) dépassent ses passifs à long terme ( $62.0M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: EVLV dispose de plus de liquidités que de sa dette totale.
Réduire la dette: EVLV avait des capitaux propres négatifs il y a 5 ans, mais ils sont désormais positifs et se sont donc améliorés.
Bilan
Analyse des pistes de trésorerie
Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.
Piste de trésorerie stable: EVLV dispose d'une piste de trésorerie suffisante pour plus de 3 ans sur la base de son flux de trésorerie disponible actuel.
Prévisions de trésorerie: EVLV dispose d'une marge de trésorerie suffisante pour 1.5 ans si le flux de trésorerie disponible continue de diminuer à un taux historique de 1 % chaque année.
Découvrir des entreprises saines
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/04 04:11 |
| Cours de l'action en fin de journée | 2026/05/01 00:00 |
| Les revenus | 2025/12/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Evolv Technologies Holdings, Inc. est couverte par 5 analystes. 4 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Jeremy Hamblin | Craig-Hallum Capital Group LLC |
| Eric Martinuzzi | Lake Street Capital Markets, LLC |
| Michael Latimore | Northland Capital Markets |